Compare COGT & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COGT | IFS |
|---|---|---|
| Founded | 2014 | 1897 |
| Country | United States | Peru |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.4B |
| IPO Year | 2018 | 2014 |
| Metric | COGT | IFS |
|---|---|---|
| Price | $38.74 | $56.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 1 |
| Target Price | $36.21 | ★ $48.00 |
| AVG Volume (30 Days) | ★ 2.7M | 384.3K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.85% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,871,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,733.58 | $7.38 |
| P/E Ratio | ★ N/A | $9.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.80 | $35.45 |
| 52 Week High | $43.73 | $58.16 |
| Indicator | COGT | IFS |
|---|---|---|
| Relative Strength Index (RSI) | 71.85 | 62.82 |
| Support Level | $37.54 | $43.65 |
| Resistance Level | $40.62 | $58.16 |
| Average True Range (ATR) | 1.49 | 2.01 |
| MACD | 0.71 | -0.03 |
| Stochastic Oscillator | 87.34 | 78.25 |
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.